Core Viewpoint - The announcement details the upcoming maturity and redemption of the "Yingke Convertible Bonds," including the conversion price, redemption amount, and tax implications for investors [1][2][3][4][5] Group 1: Convertible Bond Overview - The "Yingke Convertible Bonds" were issued on August 16, 2019, with a total issuance of 4.70 million bonds, amounting to 470 million RMB [1] - The current conversion price for the bonds is set at 3.42 RMB per share [2] Group 2: Redemption and Payment Details - The bonds will be redeemed at 128% of the face value, equating to 128 RMB per bond, including the last interest payment [2][3] - The maturity date for the bonds is August 15, 2025, with the payment date for the redemption set for August 18, 2025 [3] Group 3: Trading and Tax Implications - Trading of the "Yingke Convertible Bonds" ceased on June 29, 2021, and will be delisted on August 18, 2025 [2][4] - Individual investors are subject to a 20% tax on interest income, with the expected net payout being 127.2 RMB per bond after tax [4][5]

Trading Information Summary - On August 8, 2025, the main funds of Yingke Medical experienced a net outflow of 43.40 million yuan, while speculative funds saw a net outflow of 16.28 million yuan. In contrast, retail investors had a net inflow of 59.68 million yuan [1][3]. Company Announcement Summary - Yingke Medical Technology Co., Ltd. issued its seventh reminder announcement regarding the upcoming maturity and redemption of Yingke Convertible Bonds. The bonds are set to mature on August 15, 2025, with a redemption price of 128 yuan per bond, including the last interest payment. The final conversion date is also August 15, 2025, with a conversion price of 3.42 yuan per share [1][3]. - The company issued 4.70 million convertible bonds in August 2019, with a total issuance amount of 470 million yuan. The bonds have been in the conversion period since February 24, 2020, and will continue until August 15, 2025. The company has committed to publishing relevant announcements regarding the maturity and delisting of the bonds on the designated information disclosure website [1].

Group 1: New Stock Issuances - China Heavy Industry (601989) has a cash option declaration period from August 13, 2025[1] - China Shipbuilding (600150) has a buyback request period from August 13 to August 15, 2025[1] - Shenkai Co. (002633) has a tender offer period from July 29 to August 27, 2025[1] Group 2: Tender Offers and Mergers - ST Kelly (300326) has a tender offer period from July 17 to August 15, 2025[1] - Fushun Special Steel (600399) has a tender offer period from August 12 to September 10, 2025[1] - China Heavy Industry (601989) is involved in an absorption merger[1] Group 3: Abnormal Fluctuations - Tianlu Convertible Bond (110060) reported severe abnormal fluctuations on July 30, 2025[2] - Henghe Precision (300539) reported abnormal fluctuations on July 29, 2025[2] - ST Suwu (600200) reported abnormal fluctuations on August 6, 2025[2]

Core Points - The company, Yingke Medical Technology Co., Ltd., has issued a convertible bond known as "Yingke Convertible Bond" with a total issuance amount of 470 million yuan [1][2] - The current conversion price for the bond into company stock is set at 3.42 yuan per share [2] - The bond is scheduled to mature on August 15, 2025, and will be redeemed at 128% of the face value, which amounts to 128 yuan per bond, including the last interest payment [2][3] Group 1: Convertible Bond Details - The "Yingke Convertible Bond" was approved by the China Securities Regulatory Commission and began trading on September 10, 2019 [1] - The bond has a face value of 100 yuan per bond, with a total of 4.7 million bonds issued [1] - Trading of the bond was suspended on June 29, 2021, but holders can still convert the bonds into shares until the end of the conversion period [2] Group 2: Redemption and Trading Suspension - The company will announce the bond's maturity and redemption details on the designated information disclosure website [3] - Investors are reminded that the bond will stop trading three days before the end of the conversion period [2]

Group 1 - The company announced an adjustment to the conversion price of its convertible bonds, changing from RMB 3.26 per share to RMB 3.42 per share, effective from July 22, 2025 [1][4] - The adjustment is a result of the completion of the registration for the first grant of restricted stock under the 2025 incentive plan, which involves 12.8021 million shares, accounting for approximately 1.9946% of the total share capital before the registration [2][3] - Following the registration, the total share capital of the company will increase from 641,832,807 shares to 654,634,907 shares [3] Group 2 - The adjustment of the conversion price is in accordance with the regulations outlined in the company's prospectus and relevant guidelines from the China Securities Regulatory Commission [4] - The calculation for the new conversion price considers the previous conversion price, the price of newly issued shares, and the percentage increase in share capital due to the restricted stock grant [4]

New Stock Listings - Huadian New Energy (600930) listed at an issue price of 3.18 on July 16, 2025[1] - Zhongcheng Tui (300208) has 2 trading days remaining until the last trading day[1] - Tui Shi Jin Gang (600190) also has 2 trading days remaining until the last trading day[1] Abnormal Fluctuations - Huayin Power (600744) reported severe abnormal fluctuations on July 15, 2025[1] - Changcheng Military Industry (601606) announced abnormal fluctuations on July 15, 2025[1] - ST Yanzhen (603389) reported abnormal fluctuations on July 16, 2025[1] Other Notable Announcements - ST Ya Zhen (000627) reported significant fluctuations with a value of 7189 on July 16, 2025[3] - Guosheng Technology (603778) reported fluctuations with a value of 3370 on July 15, 2025[3] - ST Xin Chao (600777) reported fluctuations with a value of 1008 on July 11, 2025[3]

Trading Information Summary - On July 11, 2025, the stock price of Yingke Medical (300677) closed at 26.78 yuan, down 0.37%, with a turnover rate of 3.63% and a trading volume of 168,700 shares, amounting to a total transaction value of 455 million yuan [1] - On the same day, the net inflow of main funds was 25.4 million yuan, while retail investors experienced a net outflow of 21.1 million yuan [3] Company Announcements Summary - Yingke Medical adjusted the conversion price of its convertible bonds from 3.39 yuan/share to 3.26 yuan/share, effective from July 11, 2025 [1][3] - The company completed the repurchase and cancellation of 4,504,300 shares, accounting for 0.6969% of the total share capital, reducing the total share capital from 646,326,180 shares to 641,821,880 shares [2][3] - Following the share cancellation, the shareholding ratio of the controlling shareholder, Liu Fangyi, increased from 35.85% to 36.10% [2] - The "Yingke Convertible Bonds" will mature on August 15, 2025, with a redemption price of 128 yuan per bond (including the last interest payment), and the last conversion date is also August 15, 2025 [2][3]

Group 1 - The core point of the announcement is that Yingke Medical Technology Co., Ltd. is reminding holders of its convertible bonds ("Yingke Convertible Bonds") about the upcoming expiration and conversion options [1][2][3] - The "Yingke Convertible Bonds" were issued on August 16, 2019, with a total amount of 470 million yuan, and are currently trading on the Shenzhen Stock Exchange under the code "123029" [1][2] - The conversion price for the bonds is set at 3.26 yuan per share, allowing bondholders to convert their bonds into company stock during the conversion period [1][2] Group 2 - The bonds will be redeemed at 128% of their face value, which amounts to 128 yuan per bond, including the last interest payment, within five trading days after the maturity date of August 15, 2025 [2][3] - The trading of "Yingke Convertible Bonds" was suspended on June 29, 2021, and will not resume before the end of the conversion period [2] - The company will publish announcements regarding the bond's maturity and delisting on the designated information disclosure website [3]

Core Points - The stock price of Yingke Medical (300677) closed at 22.88 yuan on June 13, 2025, down 1.55% from the previous week [1] - The company's total market capitalization is 14.785 billion yuan, ranking 14th out of 126 in the medical device sector and 1051st out of 5150 in the A-share market [1] Company Announcements - The supervisory board confirmed the legality and validity of the list of incentive objects for the 2025 restricted stock incentive plan [1][3] - Yingke Convertible Bonds will resume conversion on the first trading day after the equity registration date for the 2024 annual equity distribution, which is June 13, 2025 [1][3] - The repurchase price limit for shares has been adjusted from 26.61 yuan to 26.51 yuan per share, effective June 13, 2025 [2][3] - The company has repurchased 2,523,900 shares, accounting for 0.3906% of the total share capital, with a total transaction amount of approximately 53.52 million yuan [2] - The expected number of shares to be repurchased in the future ranges from 998,922 to 2,507,786, with a total expected repurchase quantity of 3,522,822 to 5,031,686 shares, representing approximately 0.5452% to 0.7787% of the total share capital [2]